Labcorp (LH) has been making headlines lately for its robust performance in the bio-tech sector. Some key aspects of the company's recent advancements is its development of a
groundbreaking Alzheimer’s Blood Test, strong momentum stock due to strong demand for
diagnostic testing, and outperformance in Q2 earnings among
Testing & Diagnostics Services Stocks. The company has also been recognized for its initiative to simplify lab test selection through an
AI Tool,
acquisition of select assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Business, launching an
FDA-cleared Alzheimer's Diagnostic Blood Test nationwide and a 9.5% gain in Q2. The company has managed to register considerable financial growth with shares rising 1.66% after insiders sold shares, coupled with the company's plans for an
earnings call. Moreover, investors are showing confidence in the company after a 71% gain over the past five years. With strong Q1 and Q2,
Labcorp is in a position of strength that potential investors cannot ignore.
Laboratory Corporation of America Holdings LH News Analytics from Thu, 23 Jul 2020 07:00:00 GMT to Sat, 23 Aug 2025 12:39:32 GMT -
Rating 8
- Innovation 7
- Information 8
- Rumor 4
